Martina E Schmidt1, Joachim Wiskemann2, Karen Steindorf3. 1. Division of Physical Activity, Prevention and Cancer, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Im Neuenheimer Feld 581, 69120, Heidelberg, Germany. m.schmidt@dkfz.de. 2. Division of Medical Oncology, National Center for Tumor Diseases (NCT) and University Hospital Heidelberg, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany. 3. Division of Physical Activity, Prevention and Cancer, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Im Neuenheimer Feld 581, 69120, Heidelberg, Germany.
Abstract
PURPOSE: After cancer treatment, it is desirable to maintain or regain a high quality of life (QoL) and the ability to accomplish everyday tasks well. Therefore, we substantiated the scarce knowledge regarding long-term QoL after breast cancer, burdensome problems, and unmet needs for more support. METHODS: Disease-free breast cancer survivors (n = 190) who had participated in two randomized controlled exercise trials during primary treatment were followed up to 5 years post-diagnosis. QoL-related functions and symptoms (EORTC QLQ-C30/-BR23), health problems, and support needs were assessed. EORTC-QLQ scores were compared with age-matched normative values from the general population in Germany. RESULTS: QoL-related functions and symptoms in patients during cancer treatment were worse compared to healthy references, but largely improved over time. Yet, cognitive function and sleep were still significantly impaired at 5-year follow-up. Other common long-term problems included sexual issues (45% of survivors), hot flashes (38%), pain (34%), fatigue (24%), and polyneuropathy (21%). Regression analyses indicated fatigue having the strongest impact on global QoL. Support needs were expressed mainly for menopausal disorders (43%), physical performance (39%), sleep problems (38%), arthralgia (37%), cognitive problems (36%), weight problems (32%), and fatigue (31%). CONCLUSIONS: While QoL in disease-free breast cancer survivors 5 years post-diagnosis was largely comparable to the general population on average, still many survivors suffered from adverse effects. There appears to be a need for ongoing screening and support regarding fatigue, sleep problems, cognitive problems, arthralgia/pain, menopausal/sexual symptoms, physical performance, and weight problems during and several years following breast cancer therapy.
PURPOSE: After cancer treatment, it is desirable to maintain or regain a high quality of life (QoL) and the ability to accomplish everyday tasks well. Therefore, we substantiated the scarce knowledge regarding long-term QoL after breast cancer, burdensome problems, and unmet needs for more support. METHODS: Disease-free breast cancer survivors (n = 190) who had participated in two randomized controlled exercise trials during primary treatment were followed up to 5 years post-diagnosis. QoL-related functions and symptoms (EORTC QLQ-C30/-BR23), health problems, and support needs were assessed. EORTC-QLQ scores were compared with age-matched normative values from the general population in Germany. RESULTS: QoL-related functions and symptoms in patients during cancer treatment were worse compared to healthy references, but largely improved over time. Yet, cognitive function and sleep were still significantly impaired at 5-year follow-up. Other common long-term problems included sexual issues (45% of survivors), hot flashes (38%), pain (34%), fatigue (24%), and polyneuropathy (21%). Regression analyses indicated fatigue having the strongest impact on global QoL. Support needs were expressed mainly for menopausal disorders (43%), physical performance (39%), sleep problems (38%), arthralgia (37%), cognitive problems (36%), weight problems (32%), and fatigue (31%). CONCLUSIONS: While QoL in disease-free breast cancer survivors 5 years post-diagnosis was largely comparable to the general population on average, still many survivors suffered from adverse effects. There appears to be a need for ongoing screening and support regarding fatigue, sleep problems, cognitive problems, arthralgia/pain, menopausal/sexual symptoms, physical performance, and weight problems during and several years following breast cancer therapy.
Entities:
Keywords:
Breast cancer survivors; Cognitive function; Fatigue; Long-term quality of life; Menopausal symptoms; Sleep problems
Authors: Martina E Schmidt; Joachim Wiskemann; Cornelia M Ulrich; Andreas Schneeweiss; Karen Steindorf Journal: Acta Oncol Date: 2017-01-13 Impact factor: 4.089
Authors: Barbara Muzzatti; Cristiana Flaiban; Antonella Surbone; Maria Antonietta Annunziata Journal: Qual Life Res Date: 2014-10-24 Impact factor: 4.147
Authors: Martina E Schmidt; Joachim Wiskemann; Andreas Schneeweiss; Karin Potthoff; Cornelia M Ulrich; Karen Steindorf Journal: Int J Cancer Date: 2017-11-13 Impact factor: 7.396
Authors: Cara Stabile; Shari Goldfarb; Raymond E Baser; Deborah J Goldfrank; Nadeem R Abu-Rustum; Richard R Barakat; Maura N Dickler; Jeanne Carter Journal: Breast Cancer Res Treat Date: 2017-05-25 Impact factor: 4.872
Authors: Florence Joly; Bénédicte Giffard; Olivier Rigal; Michiel B De Ruiter; Brent J Small; Martine Dubois; Johan LeFel; Sanne B Schagen; Tim A Ahles; Jeffrey S Wefel; Janette L Vardy; Véronique Pancré; Marie Lange; Hélène Castel Journal: J Pain Symptom Manage Date: 2015-09-05 Impact factor: 3.612
Authors: Janne de Winter; Nicole P M Ezendam; Martijn J L Bours; Renate M Winkels; Matty P Weijenberg; Ellen Kampman; Pauline A J Vissers; Floortje Mols; Sandra Beijer Journal: Support Care Cancer Date: 2021-07-06 Impact factor: 3.603
Authors: Nora L Nock; Anastasia Dimitropoulos; Kristine M Zanotti; Steven Waggoner; Christa Nagel; Mladen Golubic; Chad M Michener; John P Kirwan; Jay Alberts Journal: Support Care Cancer Date: 2019-09-02 Impact factor: 3.603
Authors: Alejandro Álvarez-Bustos; Cristina G de Pedro; María Romero-Elías; Javier Ramos; Pablo Osorio; Blanca Cantos; Constanza Maximiano; Miriam Méndez; Carmen Fiuza-Luces; Marta Méndez-Otero; Silvia Martín; Héctor Cebolla; Ana Ruiz-Casado Journal: Support Care Cancer Date: 2021-04-28 Impact factor: 3.603
Authors: Bettina Boeer; Anna Seller; Birgitt Schoenfisch; Ute Krainick-Strobel; Andreas Dietrich; Sara Y Brucker; Diethelm Wallwiener; Andreas Niess; Markus Hahn Journal: Arch Gynecol Obstet Date: 2022-07-26 Impact factor: 2.493
Authors: Cathleen Y Xing; Michelle Doose; Bo Qin; Yong Lin; Tiffany L Carson; Jesse J Plascak; Kitaw Demissie; Chi-Chen Hong; Elisa V Bandera; Adana A M Llanos Journal: Breast Cancer Res Treat Date: 2020-09-10 Impact factor: 4.872
Authors: Nicole L Stout; Daniel Santa Mina; Kathleen D Lyons; Karen Robb; Julie K Silver Journal: CA Cancer J Clin Date: 2020-10-27 Impact factor: 508.702